The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction

NCT07381803 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2804

Enrollment

OTHER

Sponsor class

Conditions

Zhejiang University

Interventions

DRUG: Fexofenadine 60 Mg Oral Tablet
DRUG: Placebo

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University